IRIS
MARZIO, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.564
EU - Europa 5.023
AS - Asia 4.679
SA - Sud America 579
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 8
Totale 16.921
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.464
SG - Singapore 1.639
CN - Cina 1.526
UA - Ucraina 974
IE - Irlanda 777
IT - Italia 717
TR - Turchia 698
SE - Svezia 642
GB - Regno Unito 584
BR - Brasile 482
FR - Francia 446
IN - India 406
DE - Germania 345
VN - Vietnam 228
FI - Finlandia 207
RU - Federazione Russa 143
PL - Polonia 60
CA - Canada 52
MX - Messico 36
AR - Argentina 30
KR - Corea 27
EC - Ecuador 25
IQ - Iraq 25
BD - Bangladesh 23
ZA - Sudafrica 18
BE - Belgio 17
EU - Europa 17
ID - Indonesia 16
ES - Italia 15
HK - Hong Kong 15
RO - Romania 15
NL - Olanda 14
JP - Giappone 13
PY - Paraguay 12
CZ - Repubblica Ceca 11
LT - Lituania 11
CO - Colombia 10
GR - Grecia 10
IL - Israele 10
AT - Austria 9
MA - Marocco 9
PK - Pakistan 9
AU - Australia 8
CL - Cile 7
DZ - Algeria 7
KE - Kenya 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
EG - Egitto 5
IR - Iran 5
PE - Perù 5
SA - Arabia Saudita 5
PT - Portogallo 4
AZ - Azerbaigian 3
BO - Bolivia 3
CH - Svizzera 3
GT - Guatemala 3
NO - Norvegia 3
NP - Nepal 3
PS - Palestinian Territory 3
TW - Taiwan 3
UZ - Uzbekistan 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
GE - Georgia 2
JM - Giamaica 2
KZ - Kazakistan 2
MD - Moldavia 2
OM - Oman 2
SC - Seychelles 2
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
JO - Giordania 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MY - Malesia 1
PH - Filippine 1
SR - Suriname 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 16.921
Salva come PNG Salva come JPEG
Città #
Singapore 1.098
Jacksonville 1.078
Chandler 779
Dublin 764
Dearborn 458
Southend 422
Princeton 386
Dallas 335
Izmir 333
Nanjing 327
Beijing 315
Ashburn 276
Wilmington 257
Los Angeles 195
Cambridge 181
Tongling 135
Buffalo 123
Woodbridge 118
Ann Arbor 113
The Dalles 110
Santa Clara 105
Nanchang 104
New York 103
Ho Chi Minh City 82
Boardman 65
Houston 65
Council Bluffs 64
Shenyang 62
Hebei 56
Altamura 54
São Paulo 51
Munich 50
Kunming 49
Hefei 48
Rome 47
Tianjin 46
Jiaxing 44
Kraków 36
Redondo Beach 36
Chieti 35
Hanoi 35
Hangzhou 31
Jinan 26
Bologna 25
Milan 24
Norwalk 24
Grevenbroich 22
London 22
Guangzhou 21
Brooklyn 20
Dong Ket 20
Orange 20
Warsaw 20
Boston 19
Changsha 19
Seoul 19
Helsinki 17
Washington 17
Brussels 16
Denver 16
Guayaquil 16
Rio de Janeiro 16
Stockholm 16
Düsseldorf 15
Hong Kong 15
Augusta 14
Brasília 14
Turku 14
Vinh 14
Belo Horizonte 13
Chennai 13
Montreal 13
Changchun 12
Chicago 12
Da Nang 12
Johannesburg 12
Lanzhou 12
Seattle 12
Tokyo 12
Toronto 12
Baghdad 11
Charlotte 11
Frankfurt am Main 11
Pescara 11
Phoenix 11
San Francisco 11
San Mateo 11
Ningbo 10
Ankara 9
Cepagatti 9
Curitiba 9
Fuzhou 9
Guadalajara 9
Moscow 9
Orem 9
Amsterdam 8
Brno 8
Haiphong 8
L'aquila 8
Nuremberg 8
Totale 9.897
Salva come PNG Salva come JPEG
Nome #
Il tempo di transito oro-cecale (TTOC) è accelerato dopo somministrazione orale di allergene alimentare nei pazienti con sindrome del colon irritabile (SCI) e prick test positivo 387
EFFICACY OF TREATMENT WITH PYLERA IN COMBINATION WITH RANITIDINE ON FIRST-LINE INFECTION HELICOBACTER PYLORI: EXPERIENCE OF A SINGLE CENTER 185
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 164
48-Hour continuous pH measurement in patients with gastro-oesophageal reflux: effect of cisapride. 146
Beneficial effects of SR140333, a novel substance P antagonist, in a rat model of experimental colitis 144
24-hour pancolonic motility using a portable electronic probe in healthy subjects 144
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 142
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 142
SYMPTOM PATTERN IN FUNCTIONAL DYSPEPSIA AND GASTROESOPHAGEAL REFLUX DISEASE: ROLE OF H. PYLORI INFECTION 142
Antibacterial effect of plant extracts against Helicobacter pylori 141
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 136
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 135
SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis 133
Two weeks regimen with amoxillicin, tinidazole and omeprazole eradicates helicobacter pylori and cures active duodenal ulcer 132
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 132
Correlation between anal canal size and anal canal pressure: an ultrasonografhip and manometric study 128
Circadian variations in antioxidant defences and lipid peroxidation in the rat heart 128
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 126
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 126
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 126
Trasmissione di Helicobacter pylori in un modello murino 124
Anal canal diameters and pessure measured simultaneously by real time ultrasonography and manometry in human subjects 123
Diameters and pressures of the anal canal simultaneously measured with endosonography and manometry 120
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 120
Cigarette smoke, ferritin, and lipid peroxidation 120
Alterazioni contrattili della muscolatura liscia nel corso di colite sperimentale sono ridotte da un antagonista specifico della sostanza P 120
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 119
Heightened free radical activity in angina pectoris 118
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 116
L'eritromicina accelera lo svuotamento gastrico e colecistico nell'uomo attraverso un meccanismo mediato dall'acetilcolina 116
Detection of Helicobacter pylori in saliva and esophagus 115
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD) 115
COMBINED VIDEOCAPSULE ENDOSCOPY (VCE) AND LACTULOSE HYDROGEN BREATH TEST (LHBT): A COMPARATIVE STUDY TO ASSESS ORO-CECAL TRANSIT TIME (OCTT). 115
Blood cardioplegia reduces oxidant burden in the ischemic and reperfused human myocardium 115
Aortic glutathione-related antioxidant defences in rabbits subjected to suprarenal aortic coarctation hypertension 113
THE INFLUENCE OF ACID REFLUX ON THE HEART RATE VARIABILITY (HRV) IN PATIENTS WITH AND WITHOUT GASTROESOPHAGEAL REFLUX DISEASE (GERD). 113
Effect of ischemia and reperfusion on antioxidant enzymes and mitochondrial inner membrane proteins in perfused rat heart. 112
[Physiopathological bases of the medical treatment of portal hypertension]. 112
Heparin: does it act as an antioxidant in vivo? 111
Morphological and motor changes during experimental colits in rats are prevented by a specific substance p antagonist 111
ESOPHAGITIS AND ITS CAUSES: WHO IS "GUILTY" WHEN ACID IS FOUND "NOT GUILTY"? 111
Rifabutin based triple therapy for eradication of H.pylori primary and secondary resistant to tinidazole and clarithromycin 110
Detection of Helicobacter pylori in esophagus and saliva in humans 109
Pharyngeal, Esophageal and Gastric Motility in Normal Subjects and in patients with gastroesophageal Reflux Disease 108
Short- and long-term omeplazole for the tratment and prevention of duodenal ulcer, and effect on helicobacter pylori 107
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 107
5-HT1-RECEPTOR AGONIST SUMATRIPTAN MODIFIES GASTRIC SIZE AFTER 500 ML OF WATER IN DYSPEPTIC PATIENTS AND NORMAL SUBJECTS 107
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC) 107
CAN HELICOBACTER PYLORI INFECTION HAVE A ROLE ON CLINICAL APPEARANCE OF GERD? 106
PRUCALOPRIDE ACCELERATES GASTRIC AND SMALL BOWEL TRANSIT TIMES OF VIDEOCAPSULES ENDOSCOPY 106
Swallows, oesophageal and gastric motility in normal subjects and in patients with gastro-oesophageal reflux disease: a 24-h-pH-manometric study 105
MIGRATING MOTOR COMPLEX RECORDED SPONTANEOUSLY AND INDUCED BY MOTILIN AND ERYTHROMYCIN IN AN EX VIVO RABBIT INTESTINAL PREPARATION 105
EVALUATION OF INTRAPARENCHYMAL AND PORTAL BLOOD FLOW BY CONTRAST ENHANCED ULTRASOUND (CEUS) AND LIVER STIFFNESS BY FIBROSCAN IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CHRONIC HEPATITIS C (CHC). 104
Gastric antral and fundus receptive relaxation in dyspeptic patients and normal subjects 103
H2-RECEPTOR ANTAGONISTS ARE SCAVENGERS OF OXYGEN RADICALS 103
Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil. 103
Masse all'ipocondrio dx e carcinoma della colecisti 102
EFFECT OF CIMETROPIUM BROMIDE ON GALLBLADDER CONTRACTION IN RESPONSE TO ORAL AND INTRADUODENAL OLIVE OIL 101
Erythromycin accellerates gastric and gallbladder emptying through a cholinergic mediated mechanism in humans 101
Esophageal and gastric motility in patients with gastroesophageal reflux disease 100
Glutathione peroxidase, glutathione reductase and glutathione transferase activities in the human artery, vein and heart. 100
EVALUATION OF LIVER BLOOD FLOW AND FIBROSIS IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CIRRHOSIS IN COMPARISON WITH NORMAL CONTROLS THROUGH CONTRAST ENHANCED ULTRASOUND(CEUS) AND FIBROSCAN 100
TYPICAL AND ATYPICAL SYMPTOMS OF GASTRO ESOPHAGEAL REFLUX DISEASE: DOES Helicobacter pylori MATTER? 100
Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori 99
SHORT AND LONG TERM EFFICACY OF GLYCERYL TRINITRATE (GTN) OINTMENT 0.2% AND 2% ON ANAL CANAL PRESSURE IN PATIENTS WITH CHRONIC ANAL FISSURES. 99
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 98
Effect of glyceryl trinitrate ointment (GTO) 0.2% and 2% on anal canal pressure during acute and chronic application in patients with anal fissure 98
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 98
TRANSIENT LOWER ESOPHAGEAL SPHINCTER RELAXATIONS AND GASTRO-ESOPHAGEAL REFLUX EPISODES IN HEALTHY SUBJECTS AND GERD PATIENTS DURING 24 HOURS 98
Oesophageal and gastric motility in patients with gastro-oesophageal reflux disease 97
Effect of omeprazole, clarithromicin and amoxicillin for a short time on helicobacter pylori eradication 97
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 97
Role of transient lower esophageal sphincter relaxations in the genesis of priximal gastro-esophageal reflux 96
ESOPHAGEAL MOTILITY ASSESSMENT AFTER PRUCALOPRIDE ADMINISTRATION IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY (IEM) AND SYSTEMIC SCLEROSIS. 96
Distensione gastrica nei soggetti normali e nei pazienti dispeptici helicobacter pylori positivi e negativi e correlazione con i sintomi 94
Prolonged anal sphincter manometry in normal human subjects 93
Regional distribution of glutathione-related antioxidant defences in the normal rabbit aorta. 93
EFFICACIA E SICUREZZA DEL RITRATTAMENTO CON INFLIXIMAB IN UN PAZIENTE AFFETTO DA MORBO DI CROHN 93
DISORDINI MOTORI ASPECIFICI DELL’ESOFAGO 93
PRUCALOPRIDE INCREASES BASAL LES TONE IN PATIENTS WITH ESOPHAGEAL MOTILITY DISORDERS 93
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies 93
GRAVIDANZA IN UNA PAZIENTE AFFETTA DA RETTOCOLITE ULCEROSA IN TERAPIA CON INFLIXIMAB: CASO CLINICO 92
Influence of physical activity on gastric emptying of liquids in normal human subjects 92
EFFECT OF AN ACUTE INTRALUMINAL ADMINISTRATION OF CAPSAICIN ON OESOPHAGEAL MOTOR PATTERN IN GORD PATIENTS WITH INEFFECTIVE OESOPHAGAL MOTILITY 92
EFFECT OF THE 5-HT3 RECEPTOR ANTAGONIST, ONDANSETRON, ON GASTRIC SIZE IN DYSPEPTIC PATIENTS WITH IMPAIRED GASTRIC ACCOMODATION 92
Changes in the myocardial enzymatic systems (AES) induced by ischemia-reperfusion in the isolated rat heart 92
SPONTANEOUS OPENING OF LES IN ACHALASIA: AN UNCOMMON ON-LINE DOCUMENTATION BY HIGH-RESOLUTION MANOMETRY 92
Registrazione delle 24 ore della motilità del piloro in soggetti normali 91
EFFECT OF CLEBOPRIDE ON ESOPHAGEAL MOTOR FUNCTION IN GERD PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY: EVALUATION USING HIGH RESOLUTION MANOMETRY 90
Gastric antral and fundic distention evaluated by ultrasonography (US) in normal subjects and patients with idiopathic dyspepsia 89
Proximal and Distal Gastric Distension in Normal Subjects and H. pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 89
LA MALDIGESTIONE 89
La terapia chirurgica laparoscopica della malattia da reflusso gastro-esofageo 88
EFFECT OF THE 5-HT1 AGONIST SUMATRIPTAN ON ESOPHAGEAL MOTOR PATTERN IN PATIENTS WITH INEFFECTIVE ESOPHAGEAL MOTILITY 88
Sodium cromoglycate in the treatment of eosinophilic gastroenteritis. 88
ULTRASOUND(US) GRADED HEPATOSTEATOSIS ASSESSMENT THROUGH CONTRAST ENHANCED ULTRASOUND (CEUS) AND FIBROSCAN IN NON ALCOHOLIC FATTY LIVER DISEASE 88
Proximal and Distal Gastric Distension in Normal Subjects and H.pylori-Positive and -Negative Dyspeptic Patients and Correlation with Symptoms 87
I RILASCIAMENTI TRANSITORI DELLO SFINTERE ESOFAGEO INFERIORE NELLA GENESI DEI REFLUSSI GASTRO-ESOFAGEI: PROSPETTIVE TERAPEUTICHE 87
EFFECT OF HYOSCINE N-BUTYLBROMIDE ON GASTROESOPHAGEAL REFLUX IN NORMAL SUBJECTS AND PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. 87
Valore dell'ecotomografia nella diagnosi delle metastasi epatiche nei pazienti portatori di neoplasia gastrointestinale 87
Totale 11.197
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021641 0 0 0 0 0 239 14 18 80 190 23 77
2021/2022794 28 12 6 200 75 9 10 65 55 6 89 239
2022/20232.220 199 234 122 268 186 514 150 160 259 29 54 45
2023/20241.019 77 52 65 29 33 313 252 40 3 41 17 97
2024/20252.642 189 410 308 38 65 67 48 161 335 110 279 632
2025/20262.785 466 278 668 697 468 208 0 0 0 0 0 0
Totale 17.179